UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
NGNE holding history
Neurogene Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NGNE overviewAll 13F holders of NGNEFull Q4 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −34,761−100.0% | Sold out | Holders |
| Q2 2025 | 34,761 | $519.7K | <0.1% | −21,254−37.9% | Reduced | Holders |
| Q1 2025 | 56,015 | $655.9K | <0.1% | +23,281+71.1% | Added | Holders |
| Q4 2024 | 32,734 | $748.3K | <0.1% | +23,907+270.8% | Added | Holders |
| Q3 2024 | 8,827 | $370.4K | <0.1% | +1,727+24.3% | Added | Holders |
| Q2 2024 | 7,100 | $258.4K | <0.1% | +7,100 | New | Holders |